Sign in

Systematic Review Initiative

@sritransfusion.bsky.social
69 followers 105 following 46 posts

Improving the evidence base for the practice of #transfusionmedicine through undertaking and supporting others in undertaking #systematicreviews. Active since 2002. www.systematicreviewinitiative.com Our Twitter site closed at the end of 2024

PostsRepliesMedia
Systematic Review Initiative @sritransfusion.bsky.social · 02/10/2026
🩸September was #SickleCellAwareness month and also saw the publication of our updated overview of #systematicreviews, looking at red cell #transfusion interventions in #sicklecelldisease, and led by Professor Lise Estcourt. @liseestcourt.bsky.social @thrinaline.bsky.social #MedSky
Image about the article: Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
101
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 02/10/2026
🟣 New from the #StemCellEvidence alert: 📑 Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial by Wu et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial
by Wu et al.
featured in the Stem Cell Evidence Alert - September 2026
121
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
📄From the #Transfusion Evidence Alert: Albumin for people with liver cirrhosis and bacterial infections by Simonetti et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Albumin for people with liver cirrhosis and bacterial infections by Simonetti et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 01/10/2026
📄New from the #Transfusion Evidence Alert: Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates by Roumeliotis et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Larger versus smaller red blood cell volume per transfusion in hospitalized adults, children and preterm neonates by Roumeliotis et al.
Featured in the Transfusion Evidence Alert – September 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
📄New from the #Transfusion Evidence Alert: Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 30/09/2026
📄From the #Transfusion Evidence Alert: Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 30/09/2026
🟣 New from the #StemCellEvidence alert: 📑 GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al.
featured in the Stem Cell Evidence Alert - September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
📄From the #Transfusion Evidence Alert: Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026
📄New from the #Transfusion Evidence Alert: All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al.
Featured in the Transfusion Evidence Alert – September 2026
133
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
📄From the #Transfusion Evidence Alert: Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026
📄New from the #Transfusion Evidence Alert: AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al. 🔗 Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al.
Featured in the Transfusion Evidence Alert – September 2026
144
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
📄From the #Transfusion Evidence Alert: Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy By Bus et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy by Bus et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026
📆Article of the month from the #Transfusion Evidence Alert: Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial By Spinella et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial by Spinella et al.
Featured in the Transfusion Evidence Alert – September 2026
132
Systematic Review Initiative @sritransfusion.bsky.social · 24/09/2026
📆Today is #WorldCancerResearchDay. #StemCellTransplant is a valuable treatment option for some types of cancer, and our Stem Cell Evidence Library stores many articles on this topic. 🔗Link to the Stem Cell Evidence Library in replies
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 23/09/2026
🆕 The #Transfusion Evidence Alert - September 2026 is out! 🩸See the latest top articles in #TransfusionMedicine ✅Each top article has a quick-format PICO summary 🔗Link in the comments #MedSky
Image showing an extract of the Transfusion Evidence Alert
132
Systematic Review Initiative @sritransfusion.bsky.social · 18/09/2026
🩸In honour of #SickleCellAwarenessMonth this September, we are proud to highlight our latest two #systematicreviews in the field. 🔗See links for these two articles in the comments
Image showing a visual abstract for the systematic review: Interventions for chronic kidney disease in people with sickle cell diseaseImage showing a visual abstract for the systematic review: Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
100
Systematic Review Initiative @sritransfusion.bsky.social · 17/09/2026
🟠Today we are celebrating #WorldPatientSafetyDay and also five years of the Transfusion Evidence Round-Up, which we produce in partnership with @isbt.bsky.social. 🔗Read more on the SRI website (link in replies)
Picture of the ISBT-SRI Transfusion Evidence Round-Up Team
143
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🔗 #StemCellEvidence link to: CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial by Tang et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial
INTRODUCTION: Cytomegalovirus (CMV) reactivation is a major cause of mortality following haploidentical hematopoietic stem cell transplantation (haplo-HSCT). The application of conventional therapies ...
032
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🆕 From the #StemCellEvidence alert: 📑 CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial by Tang et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: 
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial 
by Tang et al.
featured in the Stem Cell Evidence Alert - July/August 2026
132
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🔗 #StemCellEvidence link to: CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results by Silbert et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
Multiantigen targeting chimeric antigen receptor (CAR) T cells have emerged as a strategy to mitigate antigen escape observed after single antigen targeting therapy. Our initial experience with a biva...
032
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026
🟣 New from the #StemCellEvidence alert: 📑 CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results by Silbert et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results 
by Silbert et al.
Link in the comments
featured in the Stem Cell Evidence Alert - July/August 2026
132
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 02/09/2026
📄New from the #Transfusion Evidence Alert: Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis By Yanyiam et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis by Yanyiam et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Systematic Review Initiative @sritransfusion.bsky.social · 01/09/2026
📆September is #BloodCancerAwarenessMonth. To honour this, episode 4 of our Talking Transfusion Podcast explores recent relevant findings, clinical challenges, and how transfusion supports those living with leukemia, lymphoma, myeloma, and related conditions. Links to the podcast here: bit.ly/45VghOf
bit.ly
Talking Transfusion Podcast
A collaborative podcast featuring the latest systematic reviews and trials
033
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 01/09/2026
📄New from the #Transfusion Evidence Alert: Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial By Mora-Gonzalez et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial by Mora-Gonzalez et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 28/08/2026
📄New from the #Transfusion Evidence Alert: Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist-Bayesian meta-analysis of randomised trials By Mendes et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist-Bayesian meta-analysis of randomised trials by Mendes et al.
Featured in the Transfusion Evidence Alert – August 2026
132
Reposted by Systematic Review Initiative
The Cochrane Collaboration @cochrane.org · 28/08/2026
In her first editorial as Editor in Chief, Rupa Sarkar reflects on the role Cochrane must play, not only as a producer of systematic reviews, but as an organization that actively defends the quality, integrity, and use of evidence. Read more: www.cochranelibrary.com/cdsr/doi/10....
Cochrane is more than a producer of systematic reviews. It is an
evidence activist organization that actively defends the quality, integrity, and essential use of evidence in public discourse. — Rupa Sarkar, Editor in Chief, Cochrane
024
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026
🔗 #StemCellEvidence link to: Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development by Pidala et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development
The incidence of chronic graft-versus-host disease (GVHD) is declining but up to 30% of survivors are still diagnosed with chronic GVHD. We conducted a prospective, multi-center, observational study t...
011
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026
🆕 From the #StemCellEvidence alert: 📑 Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development by Pidala et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:

featured in the Stem Cell Evidence Alert - July/August 2026
121
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026
🔗 #StemCellEvidence link to: Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies by Perekhrestenko et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies
Allogeneic stem cell transplantation (allo-SCT) is the only potentially curative approach for several high-risk hematologic malignancies, but high relapse rates remain a challenge. Most relapses deriv...
021
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026
🟣 New from the #StemCellEvidence alert: 📑 Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies by Perekhrestenko et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for:
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies 
by Perekhrestenko et al.

featured in the Stem Cell Evidence Alert - July/August 2026
121
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026
#StemCellEvidence link to: Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique by Ozbey et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique
BACKGROUND: Umbilical cord blood (UCB) can be collected in utero (before placental delivery) or ex utero (after placental delivery). While in utero collection is standard, ex utero collection is less ...
022
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026
🆕 From the #StemCellEvidence alert: 📑 Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique by Ozbey et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: 
Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique 
by Ozbey et al.
featured in the Stem Cell Evidence Alert - July/August 2026
122
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026
🔗 #StemCellEvidence link to: Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation by Nishiwaki et al. www.stemcellevidence.com/alerts/artic... #MedSky
stemcellevidence.com
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation
Donor selection in allogeneic haematopoietic stem cell transplantation (allo-HSCT) requires balancing donor safety and recipient survival. We aimed to identify dual-association donor factors (DADFs)-d...
022
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026
🟣 New from the #StemCellEvidence alert: 📑 Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation by Nishiwaki et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: 
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation 
by Nishiwaki et al.
featured in the Stem Cell Evidence Alert - July/August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 27/08/2026
📄From the #Transfusion Evidence Alert: HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial by McComish et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial by McComish et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 26/08/2026
📄New from the #Transfusion Evidence Alert: Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis By Huang et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis by Huang et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 25/08/2026
📄New from the #StemCellEvidence alert: Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee by Gurnari et al. 🔗Link in the replies #MedSky
Image showing PICO summary for:
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee by Gurnari et al.
Featured in the Stem Cell Evidence Alert - August 2026
133
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 25/08/2026
📄From the #StemCellEvidence alert: High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial by Illerhaus et al. 🔗Link in the replies #MedSky
Image showing PICO summary for:
High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial by Illerhaus et al.
Featured in the Stem Cell Evidence Alert - August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 25/08/2026
📄From the #Transfusion Evidence Alert: Optimal Route of Tranexamic Acid Administration in Total Knee Arthroplasty: A Bayesian Network Meta-Analysis with Decision-Analytic Cost Evaluation by Hershfeld et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Optimal Route of Tranexamic Acid Administration in Total Knee Arthroplasty: A Bayesian Network Meta-Analysis with Decision-Analytic Cost Evaluation by Hershfeld et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 21/08/2026
📄From the #Transfusion Evidence Alert: Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework by Etherington et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework by Etherington et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 20/08/2026
📄New from the #Transfusion Evidence Alert: Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial By Al-Samkari et al. 🔗Transfusion Evidence Library link in replies
Image showing a PICO summary for:
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial by Al-Samkari et al.
Featured in the Transfusion Evidence Alert – August 2026
122
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 19/08/2026
🟣 From the #StemCellEvidence alert: 🆕 Infection Burden in Mismatched Unrelated Donor #HematopoieticCellTransplantation: Results from the ACCESS Trial by Auletta et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for the article:
Infection Burden in Mismatched Unrelated Donor #HematopoieticCellTransplantation: Results from the ACCESS Trial 
by Auletta et al.
featured in the Stem Cell Evidence Alert - July/August 2026
122
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 18/08/2026
🆕 The #StemCellEvidence alert for July/August is out! 🟣 See link in the comments.
Image showing an extract of the Stem Cell Evidence Alert - July/August 2026
132
Reposted by Systematic Review Initiative
Stem Cell Evidence @stemcellevidence.bsky.social · 19/08/2026
✅ New from the #StemCellEvidence alert: 📑 Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission (...) by Maffini et al. 🔗 Link in the comments #MedSky
Image showing a PICO summary for: 
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation 
by Maffini et al.
featured in the Stem Cell Evidence Alert - July/August 2026
132
Systematic Review Initiative @sritransfusion.bsky.social · 13/08/2026
📝Thank you to all who completed the @jameslindalliance.bsky.social PSP Blood Transfusion and Donation update survey this year. 🔗An article containing survey findings and a progress update is available here on the SRI website: bit.ly/4cnb2ub
bit.ly
Update: JLA PSP Blood Transfusion and Donation Update Survey - Systematic Review Initiative
Background and progress update on the JLA PSP Blood Transfusion and Donation survey
021
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 31/07/2026
📆Article of the month from the #Transfusion Evidence Alert: Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery by Houston et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery by Houston et al.
Featured in the Transfusion Evidence Alert – July 2026
123
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 30/07/2026
📄From the #Transfusion Evidence Alert: The effect of active warming and conventional body temperature management on perioperative blood loss and coagulation function in patients undergoing scoliosis correction: a multicenter randomized controlled trial by Yan et al. 🔗Link in replies #MedSky
Image showing a PICO summary for:
The effect of active warming and conventional body temperature management on perioperative blood loss and coagulation function in patients undergoing scoliosis correction: a multicenter randomized controlled trial by Yan et al.
Featured in the Transfusion Evidence Alert – July 2026
122
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 29/07/2026
📄New from the #Transfusion Evidence Alert: Artificial Intelligence-based predictive models for adverse blood donor reactions: a systematic review of immediate and delayed events and clinical data approaches by ShojaeiBaghini et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Artificial Intelligence-based predictive models for adverse blood donor reactions: a systematic review of immediate and delayed events and clinical data approaches by ShojaeiBaghini et al.
Featured in the Transfusion Evidence Alert – July 2026
122
Systematic Review Initiative @sritransfusion.bsky.social · 29/07/2026
📆28 July was #WorldHepatitisDay. In honour of this, Dr Jade King, Hepatology Specialty Registrar and NHSBT Clinical Research Fellow leading the EquiLT-UK project, has written a blog on why this area of research matters and how working with the SRI helped shape the project. 🔗Link to blog in replies.
142
Reposted by Systematic Review Initiative
Transfusion Evidence Library @transfusionlib.bsky.social · 24/07/2026
📄From the #Transfusion Evidence Alert: Effect of tranexamic acid for acute spontaneous intracerebral haemorrhage: a systematic review and individual patient data meta-analysis by Menon et al. 🔗Transfusion Evidence Library link in replies #MedSky
Image showing a PICO summary for:
Effect of tranexamic acid for acute spontaneous intracerebral haemorrhage: a systematic review and individual patient data meta-analysis by Menon et al.
Featured in the Transfusion Evidence Alert – July 2026
122